Agoracom Blog

INTERVIEW: GrowPros (GCI:CSE) Natural Pharmaceuticals Derived From Cannabis and Other Medicinal Plants @growprosmmp $

Posted by AGORACOM-JC at 9:46 AM on Wednesday, September 14th, 2016

Comprised Of Two Divisions

Pharmaceutical Division – PhytoPain Pharma

  • A new subsidiary created June 2, 2016. 80% Ownership
  • Mission is the development and commercialization of botanical based pharmaceuticals
  • A clinical stage drug development company engaged in the development of medication to alleviate symptoms related to: Pain,
    Insomnia, anxiety disorder, in patients suffering from Cancer and other, chronic and terminal diseases


  • A Physician’s decision to prescribe a new drug or even a natural health product has to be based on Evidence-Based Medicine > A legal, ethical requirement
  • Currently, no body of evidence exists to not support the prescription or recommendation of medical marijuana in any medical condition, including terminal cancer
  • The GrowPros pharmaceutical product development plan would provide the data necessary for physicians to prescribe or recommend our products

Hub On AGORACOM / Watch Interview Now!

Tags: , , ,

Comments are closed.